MENU
+Compare
CE
Stock ticker: NYSE
AS OF
Apr 3, 04:59 PM (EDT)
Price
$47.21
Change
-$9.37 (-16.56%)
Capitalization
19.17B

CE Celanese Corp Forecast, Technical & Fundamental Analysis

Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives... Show more

CE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for CE with price predictions
Apr 02, 2025

CE's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for CE turned positive on March 07, 2025. Looking at past instances where CE's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CE's RSI Oscillator exited the oversold zone, of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CE advanced for three days, in of 321 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 231 cases where CE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 31, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CE as a result. In of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.693) is normal, around the industry mean (3.647). P/E Ratio (9.508) is within average values for comparable stocks, (34.248). Projected Growth (PEG Ratio) (16.320) is also within normal values, averaging (6.088). Dividend Yield (0.016) settles around the average of (0.038) among similar stocks. P/S Ratio (1.711) is also within normal values, averaging (94.064).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.

View a ticker or compare two or three
CE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CE is expected to report earnings to fall 72.92% to 39 cents per share on May 07

Celanese Corp CE Stock Earnings Reports
Q1'25
Est.
$0.39
Q4'24
Beat
by $0.20
Q3'24
Missed
by $0.41
Q2'24
Missed
by $0.34
Q1'24
Beat
by $0.17
The last earnings report on February 18 showed earnings per share of $1.45, beating the estimate of $1.25. With 1.59M shares outstanding, the current market capitalization sits at 19.17B.
A.I.Advisor
published Dividends

CE paid dividends on March 11, 2025

Celanese Corp CE Stock Dividends
А dividend of $0.03 per share was paid with a record date of March 11, 2025, and an ex-dividend date of February 25, 2025. Read more...
A.I. Advisor
published General Information

General Information

a producer of industrial chemicals

Industry ChemicalsSpecialty

Profile
Fundamentals
Details
Industry
Chemicals Major Diversified
Address
222 West Las Colinas Boulevard
Phone
+1 972 443-4000
Employees
12410
Web
https://www.celanese.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LCTX0.440.03
+6.37%
Lineage Cell Therapeutics
FIHL16.680.21
+1.28%
Fidelis Insurance Holdings Limited
SGI62.480.23
+0.37%
Somnigroup International Inc.
HLLY2.57N/A
N/A
Holley
PCSA0.30-0.11
-27.18%
Processa Pharmaceuticals

CE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CE has been closely correlated with HUN. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if CE jumps, then HUN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CE
1D Price
Change %
CE100%
+1.62%
HUN - CE
68%
Closely correlated
+0.58%
SXYAY - CE
55%
Loosely correlated
+0.08%
AKZOY - CE
54%
Loosely correlated
+1.26%
HDSN - CE
54%
Loosely correlated
+1.99%
ARKAY - CE
52%
Loosely correlated
+0.47%
More